Completed NA INTERVENTIONAL 2-arm NCT03480295

Effects of a PF Ophthalmic Solution Containing HA0.4% and TAU 0.5%

Exploring the Effects of a Preservative-free Ophthalmic Solution Containing Hyaluronic Acid 0.4% and Taurine 0.5% on the Ocular Surface of Glaucoma Patients Under Multiple Long-term Topical Hypotensive Therapy

Sponsor: Fondazione G.B. Bietti, IRCCS

Conditions Glaucoma

Interventions Hyaluronic acid 0.2% Hyaluronic acid 0.4% and Taurine 0.5%

Updated 5 times since 2018 Last updated: Mar 27, 2018 Started: Dec 19, 2016 Primary completion: Apr 27, 2017 Completion: Apr 27, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Glaucoma, this trial is completed. The trial is conducted by Fondazione G.B. Bietti, IRCCS and has accumulated 5 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Apr 2018 — Jun 2018 [monthly]

Completed NA

First recorded

Dec 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fondazione G.B. Bietti, IRCCS

Data source: Fondazione G.B. Bietti, IRCCS

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.